MTVA
MetaVia Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.26M
P/E Ratio
—
EPS
$-7.35
Beta
0.34
52W High
$23.10
52W Low
$1.17
50-Day MA
$1.67
200-Day MA
$6.80
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About MetaVia Inc.
MetaVia Inc. is an innovative technology firm at the forefront of delivering cutting-edge digital solutions aimed at enhancing connectivity and productivity across various industries. Leveraging advanced artificial intelligence and cloud computing, the company offers scalable platforms tailored to meet the distinct needs of its diverse clientele. MetaVia's strong commitment to sustainability and social responsibility not only aligns with evolving market demands but also positions it for substantial growth, ultimately enhancing shareholder value. With a strategic approach centered on adaptability and collaboration, MetaVia is poised to thrive and lead in the rapidly changing technology landscape.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-13.69M |
| Operating Margin | 0.00% |
| Return on Equity | -195.60% |
| Return on Assets | -62.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.31 |
| Price-to-Book | 1.20 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -0.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $5.09M |
| Float | $3.31M |
| % Insiders | 34.98% |
| % Institutions | 3.09% |
Analyst Ratings
Consensus ($19.33 target)
1
Strong Buy2
BuyData last updated: 4/9/2026